PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BOXE.L vs. VERA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BOXE.L and VERA is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

BOXE.L vs. VERA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tritax EuroBox plc GBp (BOXE.L) and Vera Therapeutics, Inc. (VERA). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
1.36%
-10.19%
BOXE.L
VERA

Key characteristics

Fundamentals

Market Cap

BOXE.L:

€666.02M

VERA:

$2.35B

EPS

BOXE.L:

-€0.03

VERA:

-$2.61

Total Revenue (TTM)

BOXE.L:

€21.08M

VERA:

$0.00

Gross Profit (TTM)

BOXE.L:

€13.02M

VERA:

$952.00K

EBITDA (TTM)

BOXE.L:

-€14.63M

VERA:

-$103.90M

Returns By Period


BOXE.L

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

VERA

YTD

-19.51%

1M

-8.05%

6M

-10.30%

1Y

-24.17%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BOXE.L vs. VERA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BOXE.L
The Risk-Adjusted Performance Rank of BOXE.L is 7070
Overall Rank
The Sharpe Ratio Rank of BOXE.L is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of BOXE.L is 6969
Sortino Ratio Rank
The Omega Ratio Rank of BOXE.L is 7070
Omega Ratio Rank
The Calmar Ratio Rank of BOXE.L is 6767
Calmar Ratio Rank
The Martin Ratio Rank of BOXE.L is 7272
Martin Ratio Rank

VERA
The Risk-Adjusted Performance Rank of VERA is 3535
Overall Rank
The Sharpe Ratio Rank of VERA is 3737
Sharpe Ratio Rank
The Sortino Ratio Rank of VERA is 3737
Sortino Ratio Rank
The Omega Ratio Rank of VERA is 3636
Omega Ratio Rank
The Calmar Ratio Rank of VERA is 2929
Calmar Ratio Rank
The Martin Ratio Rank of VERA is 3636
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BOXE.L vs. VERA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Tritax EuroBox plc GBp (BOXE.L) and Vera Therapeutics, Inc. (VERA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BOXE.L, currently valued at 1.46, compared to the broader market-2.000.002.004.001.46-0.45
The chart of Sortino ratio for BOXE.L, currently valued at 2.40, compared to the broader market-6.00-4.00-2.000.002.004.002.40-0.36
The chart of Omega ratio for BOXE.L, currently valued at 1.37, compared to the broader market0.501.001.502.001.370.96
The chart of Calmar ratio for BOXE.L, currently valued at 0.79, compared to the broader market0.002.004.006.000.79-0.74
The chart of Martin ratio for BOXE.L, currently valued at 6.43, compared to the broader market0.0010.0020.0030.006.43-1.29
BOXE.L
VERA


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
1.46
-0.45
BOXE.L
VERA

Dividends

BOXE.L vs. VERA - Dividend Comparison

Neither BOXE.L nor VERA has paid dividends to shareholders.


TTM202420232022202120202019
BOXE.L
Tritax EuroBox plc GBp
5.06%5.06%7.95%7.54%4.21%4.31%3.41%
VERA
Vera Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

BOXE.L vs. VERA - Drawdown Comparison


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-39.98%
-31.58%
BOXE.L
VERA

Volatility

BOXE.L vs. VERA - Volatility Comparison

The current volatility for Tritax EuroBox plc GBp (BOXE.L) is 0.00%, while Vera Therapeutics, Inc. (VERA) has a volatility of 13.25%. This indicates that BOXE.L experiences smaller price fluctuations and is considered to be less risky than VERA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February0
13.25%
BOXE.L
VERA

Financials

BOXE.L vs. VERA - Financials Comparison

This section allows you to compare key financial metrics between Tritax EuroBox plc GBp and Vera Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. BOXE.L values in EUR, VERA values in USD
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab